KARA GROSSMAN: Open Payments
NPI 1295501872 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $410 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $234 |
| ConvaTec Inc. | 2 | $174 |
| Sumitomo Pharma America, Inc. | 8 | $174 |
| UROGEN PHARMA, INC. | 2 | $53 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| ABBVIE INC. | 1 | $16 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
Products named: GEMTESA, GENTLECATH, Axonics, AMS 700, JELMYTO, GENTLECATH GLIDE, PYLARIFY, LILETTA.
Industry payments across KS — which companies pay providers there.
